Radiomics features for assessing tumor-infiltrating lymphocytes correlate with molecular traits of triple-negative breast cancer
Guan-Hua Su(Fudan University Shanghai Cancer Center), Yajia Gu(Fudan University Shanghai Cancer Center), He Wang(Shanghai Center for Brain Science and Brain-Inspired Technology), Yan Chen(University of Nottingham), Chao You(Fudan University Shanghai Cancer Center), Yi Xiao(Fudan University Shanghai Cancer Center), Rencheng Zheng(Shanghai Center for Brain Science and Brain-Inspired Technology), Lin Jiang(Fudan University Shanghai Cancer Center)
Cited by 64
Related Papers
Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
|Cell Research|2022|315
Technological advances in cancer immunity: from immunogenomics to single-cell analysis and artificial intelligence
|Signal Transduction and Targeted Therapy|2021|171
Radiomics in breast cancer: Current advances and future directions
|Cell Reports Medicine|2024|143
Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets
|Science Advances|2023|114
Radiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancer
|Cell Reports Medicine|2022|92